出版社 | MarketsandMarkets |
出版年月 | 2024年12月 |
AI in Oncology Market – Global Forecast To 2030
The global AI in Oncology market is projected to reach USD 11.52 billion by 2030 from USD 2.45 billion in 2024, at a CAGR of 29.4% from 2024 to 2030.
世界の腫瘍学市場におけるAIは、2024年から 2030年までの CAGR 29.4% で、2024年の 24 億 5,000 万米ドルから 2030年までに 115 億 2,000 万米ドルに達すると予測されています。

Prominent players in the AI in Oncology market include are Siemens Healthineers (Germany), GE Healthcare (US), ConcertAI (US), Medtronic (Ireland), F. Hoffmann-La Roche Ltd (Switzerland), Oracle(US), NVIDIA Corporation(US), Koninklijke Philips N.V. (Netherlands), PathAI, Inc. (US), CureMetrix, Inc. (US), Mindpeak GmbH (Germany), Paige AI, Inc. (US), Predictive Oncology (US), Exscientia (UK), Insilico Medicine (US), Iktos (Paris), Tempus (US), Azra AI (US), CureMatch, Inc. (US), OncoLens (US), Triomics (US), Clinakos. (US), Perthera, Inc (US), Cellworks Group, Inc. (US), and biomy, Inc. (Japan).
The report provides insights on the following pointers:
- Analysis of key drivers (supportive regulations, growing necessity to reduce healthcare costs, reduction in costs and improved operational efficiency with AI in oncology platforms, rising demand for streamlined clinical trials, technological advancements in AI algorithms, rising cancer prevalence globally), restraints (ensuring data security is a major concern for both patients and users, elevated costs associated with adoption of AI, resistance to adoption), opportunities (focus on personalized treatment plans, collaborative efforts, AI-driven drug discovery), and challenges (limited availability of datasets, interoperability issues) influencing the growth of the AI in oncology market
- Solution Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the AI in oncology market
- Market Development: Comprehensive information about lucrative markets – the report analyses the AI in oncology market across varied regions.
- Market Diversification: Exhaustive information about new solutions, untapped geographies, recent developments, and investments in the AI in oncology market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players such as Siemens Healthineers (Germany), GE Healthcare (US), ConcertAI (US), Medtronic (Ireland), F. Hoffmann-La Roche Ltd (Switzerland), Oracle(US), NVIDIA Corporation(US), Koninklijke Philips N.V. (Netherlands), PathAI, Inc. (US), CureMetrix, Inc. (US), Mindpeak GmbH (Germany), Paige AI, Inc. (US), Predictive Oncology (US), Exscientia (UK), and Insilico Medicine (US), among others in AI in oncology market.